Evelo Biosciences Inc (EVLO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EVLO Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Evelo Biosciences Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent17.26
Cash & Short-term Investments17.00
Prepaid Expense And Other Assets Current1.67
Total Current Assets18.94
Equipment/Property/Plant Net0.89
Other Assets, Noncurrent0.80
Operating Lease Right Of Use Asset0.00
Total Assets20.63
Liabilities
Accounts Payable, Current AC0.53
Accrued Liabilities, Current AC4.55
Long-term Debt, Current Maturities LO33.95
Other Liabilities, Current0.74
Total Current Liabilities39.76
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent7.57
Operating Lease Liability Current-
Operating Lease Liability Noncurrent0.00
Total Liabilities47.33
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock561.30
Retained Earnings / Accumulated Deficit-588.03
Other Equity0.00
Common Stockholder's Equity-26.71
Total Stockholder's Equity-26.71
Liabilities & Stockholder's Equity20.63
4 historic quarters locked

Sign in to unlock the full Evelo Biosciences Inc balance sheet history.

About Evelo Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001694665-23-000182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.